The Renin Angiotensin Aldosterone System in Obesity and Hypertension Roles in the Cardiorenal Metabolic Syndrome

被引:119
|
作者
Cabandugama, Peminda K. [1 ]
Gardner, Michael J. [1 ]
Sowers, James R. [1 ,2 ,3 ]
机构
[1] Univ Missouri, Dept Med, Diabet & Cardiovasc Ctr, Div Endocrinol, D109 Diabet Ctr UHC,One Hosp Dr, Columbia, MO 65212 USA
[2] Univ Missouri, Dept Physiol & Pharmacol, One Hosp Dr, Columbia, MO 65212 USA
[3] Harry S Truman VA Hosp, 800 Hosp Dr, Columbia, MO 65201 USA
基金
美国国家卫生研究院;
关键词
Obesity; Insulin resistance; Angiotensin II; Adipocyte; Hypertension; ADIPOSE-TISSUE; SYMPATHETIC ACTIVATION; INSULIN-RESISTANCE; DIABETES-MELLITUS; LEPTIN; INHIBITION; DIET; DEFICIENCY; SOCIETY;
D O I
10.1016/j.mcna.2016.08.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the United States, more than 50 million people have blood pressure at or above 120/80 mm Hg. All components of cardiorenal metabolic syndrome (CRS) are linked to metabolic abnormalities and obesity. A major driver for CRS is obesity. Current estimates show that many of those with hypertension and CRS show some degree of systemic and cardiovascular insulin resistance. Several pathophysiologic factors participate in the link between hypertension and CRS. This article updates recent literature with a focus on the function of insulin resistance, obesity, and renin angiotensin aldosterone system-mediated oxidative stress on endothelial dysfunction and the pathogenesis of hypertension.
引用
收藏
页码:129 / +
页数:11
相关论文
共 50 条
  • [21] T-Lymphocyte-Based Renin Angiotensin System in Obesity
    Coppo, Mirella
    Bandinelli, Manuela
    Chiostri, Marco
    Poggesi, Loredana
    Boddi, Maria
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 358 (01) : 51 - 58
  • [22] The role of renin-angiotensin system inhibition in the treatment of hypertension in metabolic syndrome: are all the angiotensin receptor blockers equal?
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    Athyros, Vasilios G.
    Kakafika, Anna I.
    Tziomalos, Konstantinos
    Liberopoulos, Evangelos N.
    Florentin, Matilda
    Elisaf, Moses
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (02) : 191 - 205
  • [23] The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity
    Frigolet, Maria E.
    Torres, Nimbe
    Tovar, Armando R.
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2013, 24 (12) : 2003 - 2015
  • [24] Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus
    Hayden, Melvin R.
    Sowers, Kurt M.
    Pulakat, Lakshmi
    Joginpally, Tejaswini
    Krueger, Bennett
    Whaley-Connell, Adam
    Sowers, James R.
    CARDIORENAL MEDICINE, 2011, 1 (03) : 193 - 210
  • [25] The Role of the Renin-Angiotensin-Aldosterone System in Obesity-Related Renal Diseases
    Ruester, Christiane
    Wolf, Gunter
    SEMINARS IN NEPHROLOGY, 2013, 33 (01) : 44 - 53
  • [26] The (pro)renin receptor: an emerging player in hypertension and metabolic syndrome
    Ramkumar, Nirupama
    Kohan, Donald E.
    KIDNEY INTERNATIONAL, 2019, 95 (05) : 1041 - 1052
  • [27] The adipose tissue and the involvement of the renin-angiotensin-aldosterone system in cardiometabolic syndrome
    Borghi, F.
    Seva-Pessoa, B.
    Grassi-Kassisse, D. M.
    CELL AND TISSUE RESEARCH, 2016, 366 (03) : 543 - 548
  • [28] Evidence for renoprotection by blockade of the renin–angiotensin–aldosterone system in hypertension and diabetes
    J Karalliedde
    G Viberti
    Journal of Human Hypertension, 2006, 20 : 239 - 253
  • [29] Targeting Hypertension in Patients with Cardiorenal Metabolic Syndrome
    Rojas, Edward
    Velasco, Manuel
    Bermudez, Valmore
    Israili, Zafar
    Bolli, Peter
    CURRENT HYPERTENSION REPORTS, 2012, 14 (05) : 397 - 402
  • [30] The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome
    Putnam, Kelly
    Shoemaker, Robin
    Yiannikouris, Frederique
    Cassis, Lisa A.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 302 (06): : H1219 - H1230